Chronic stress as a risk factor for Alzheimer's disease: Roles of microglia-mediated synaptic remodeling,

Kanchan Bisht1, Kaushik Sharma1, Marie-Ève Tremblay1,2

  • 1Axe Neurosciences, CRCHU de Québec-Université Laval, Québec, QC, Canada.

Insights

Chronic stress impacts microglia, the brain's immune cells, increasing Alzheimer's disease (AD) risk. Understanding these stress-modulated microglial functions offers new therapeutic targets for AD.

Area of Science:

  • Neuroscience
  • Immunology
  • Neurodegenerative Diseases

Background:

  • Microglia are central nervous system (CNS) immune cells vital for homeostasis, synaptic plasticity, learning, and memory.
  • Chronic stress is a significant risk factor for neurodegenerative diseases like Alzheimer's disease (AD).
  • Microglia play complex roles in AD, contributing to pathology (Aβ accumulation, tau tangles) and potentially offering neuroprotection (Aβ phagocytosis).

Purpose of the Study:

  • To review the intricate relationship between chronic stress and Alzheimer's disease (AD) pathology.
  • To elucidate the multifaceted roles of microglia in AD pathogenesis.
  • To highlight stress-induced microglial phenotypes and their potential for neuroprotection in AD.

Main Methods:

  • Literature review focusing on the interplay between chronic stress, microglial function, and AD.
  • Analysis of current research on microglial phenotypes in the context of stress and AD.
  • Synthesis of findings to identify therapeutic opportunities.

Main Results:

  • Chronic stress significantly modulates microglial functions, influencing AD risk and progression.
  • Specific microglial phenotypes associated with both neuroprotection and neurodegeneration under chronic stress and AD conditions have been identified.
  • These phenotypes offer insights into the dual role of microglia in AD.

Conclusions:

  • Chronic stress is a critical environmental factor influencing microglial activity in AD.
  • Targeting stress-modulated microglial phenotypes presents a promising avenue for developing novel AD therapeutics.
  • Further research into these specific microglial states could lead to more effective interventions for AD patients.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...